Stefan Seibold
Overview
Explore the profile of Stefan Seibold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuern C, Krenacs L, Starke S, Heimrich J, Palmetshofer A, Holtmann B, et al.
Int J Oncol
. 2011 Dec;
40(4):1079-88.
PMID: 22200760
The microtubule associated tumor suppressor gene 1 (MTUS1) is a recently published tumor suppressor gene, which has also been shown to act as an early component in the growth inhibitory...
2.
Melcher R, Hartmann E, Zopf W, Herterich S, Wilke P, Muller L, et al.
Carcinogenesis
. 2011 Feb;
32(4):636-42.
PMID: 21297112
Background And Aims: Tumor suppressor genes are often located in frequently deleted chromosomal regions of colorectal cancers (CRCs). In contrast to microsatellite stable (MSS) tumors, only few loss of heterozygosity...
3.
Zuern C, Heimrich J, Kaufmann R, Richter K, Settmacher U, Wanner C, et al.
Oncol Rep
. 2009 Dec;
23(1):183-9.
PMID: 19956880
Loss of proliferative control and failure to undergo cellular differentiation are key events during carcinogenesis. We recently identified a new potential tumor suppressor gene named MTUS1 (mitochondrial tumor suppressor 1),...
4.
Galle J, Hansen-Hagge T, Wanner C, Seibold S
Atherosclerosis
. 2005 Nov;
185(2):219-26.
PMID: 16288760
Oxidized LDL (OxLDL) is a proatherogenic lipoprotein, accumulating in the vascular wall and contributing to the pathogenesis of vascular dysfunction early in the development of atherosclerosis. Enhanced serum levels of...
5.
Raff U, Schneider R, Gambaryan S, Seibold S, Reber M, Vornberger N, et al.
Nephron Physiol
. 2005 Jul;
101(3):p39-50.
PMID: 15990449
Background: L-Arginine (L-Arg), a substrate of nitric oxide synthases, improves renal function in ischemic acute renal failure (iARF). We evaluated whether L-Arg improves renal morphology and cell survival in the...
6.
Seibold S, Schurle D, Heinloth A, Wolf G, Wagner M, Galle J
J Am Soc Nephrol
. 2004 Dec;
15(12):3026-34.
PMID: 15579505
Oxidized LDL (OxLDL) induces proliferation in human umbilical vein endothelial cells (HUVEC). The influence of OxLDL on the cyclin-dependent kinase inhibitor p27(Kip1), on the activity of the small GTPase RhoA...
7.
Galle J, Seibold S
Nephrol Dial Transplant
. 2003 Aug;
18(8):1452-5.
PMID: 12897080
No abstract available.
8.
Galle J, Seibold S, Wanner C
Kidney Blood Press Res
. 2003 May;
26(2):65-75.
PMID: 12771529
Uremic patients suffer to an extremely high degree from cardiovascular disease. Cardiovascular disease results mainly from atherosclerotic remodeling of the arterial system. Inflammation is considered to contribute significantly to development...
9.
Galle J, Mameghani A, Bolz S, Gambaryan S, Gorg M, Quaschning T, et al.
J Am Soc Nephrol
. 2003 May;
14(6):1471-9.
PMID: 12761247
RhoA stimulates vascular tone by increasing smooth muscle Ca(2+) sensitivity, e.g., in atherosclerosis. This study was an investigation of the influence of oxidized LDL (OxLDL), which accumulates in atherosclerotic plaques,...
10.
Gross O, Netzer K, Lambrecht R, Seibold S, Weber M
Nephrol Dial Transplant
. 2003 May;
18(6):1122-7.
PMID: 12748344
Background: Alport syndrome (AS) is a common hereditary cause for end-stage renal failure due to a defect in type IV collagen genes. The molecular pathogenesis of benign familial haematuria (BFH)...